Long-Term Remission Achieved by Ponatinib and Donor Lymphocytes Infusion in a Ph+ Acute Lymphoblastic Leukemia Patient in Molecular Relapse After Allogenic Stem Cell Transplant and Dasatinib: A Case Report.
- DOI
- 10.3389/fonc.2020.00967
- Published
- 2020
- Container
- Frontiers in oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2020.00967,
title = {Long-Term Remission Achieved by Ponatinib and Donor Lymphocytes Infusion in a Ph+ Acute Lymphoblastic Leukemia Patient in Molecular Relapse After Allogenic Stem Cell Transplant and Dasatinib: A Case Report.},
author = {Botta C and Caruso N and Bossio S and Storino F and Console G and Martino M and Mendicino F and Lucia E and Morelli R and Correale P and Morabito F and Gentile M and Vigna E},
year = {2020},
journal = {Frontiers in oncology},
doi = {10.3389/fonc.2020.00967},
url = {https://doi.org/10.3389/fonc.2020.00967}
}RIS
TY - JOUR TI - Long-Term Remission Achieved by Ponatinib and Donor Lymphocytes Infusion in a Ph+ Acute Lymphoblastic Leukemia Patient in Molecular Relapse After Allogenic Stem Cell Transplant and Dasatinib: A Case Report. AU - Botta C AU - Caruso N AU - Bossio S AU - Storino F AU - Console G AU - Martino M AU - Mendicino F AU - Lucia E AU - Morelli R AU - Correale P AU - Morabito F AU - Gentile M AU - Vigna E PY - 2020 JO - Frontiers in oncology DO - 10.3389/fonc.2020.00967 UR - https://doi.org/10.3389/fonc.2020.00967 ER -
APA
C, B., N, C., S, B., F, S., G, C., M, M., F, M., E, L., R, M., P, C., F, M., M, G., & E, V. (2020). Long-Term Remission Achieved by Ponatinib and Donor Lymphocytes Infusion in a Ph+ Acute Lymphoblastic Leukemia Patient in Molecular Relapse After Allogenic Stem Cell Transplant and Dasatinib: A Case Report.. Frontiers in oncology. https://doi.org/10.3389/fonc.2020.00967
Source records
- pubmed · retrieved 2026-09-26T19:34:06.980Z